News

Parliamentary Pathfinder NHS Innovation Adoption Awards  The UK Dementia Trials Network (UKDTN) has been named a finalist in the Partnership Excellence Award at the Parliamentary Pathfinder NHS Innovation Adoption Awards 2026. 

UKDTN joins Alzheimer’s Society Annual Conference 2026 The UK Dementia Trials Network (UKDTN) was pleased to join the Alzheimer’s Society Annual Conference 17 September 2026, bringing together more than 450 delegates

Alzheimer’s Society UKDTN Research Nurse shortlisted for national nursing award We’re proud to share that Samuel Agyapong, an Alzheimer’s Society UKDTN Research Nurse based at Oxford’s UKDTN Site, has been shortlisted

UKDTN expands portfolio of dementia clinical trials with leading industry partners 10 trials in 1 year The UK Dementia Trials Network (UKDTN) is continuing to expand its portfolio of clinical trials,

Applications open for ARUK Doctoral Clinical Fellowship and UKDTN Clinical Trial Placement Pilot Clinicians interested in building a career in dementia clinical research are invited to apply for the Alzheimer’s Research

UKDTN was proud to participate in the Alzheimer’s Association International Conference (AAIC) 2026, held in London. Bringing together more than 10,000 researchers, clinicians, industry leaders and healthcare professionals from across the

Promising Phase 2 findings presented at the Alzheimer’s Association International Conference (AAIC) 2026 have demonstrated that the investigational therapy diranersen slowed cognitive decline while significantly reducing tau pathology in people with

A recent study, led by UKDTN’s Director – Professor Catherine Mummery – evaluated ImmunoBrain’s IBC-Ab002, a monoclonal antibody designed to modulate immune responses associated with Alzheimer’s Disease and support the brain’s